Stevens-Johnson syndrome: Difference between revisions
From IDWiki
(Created page with " == Etiology == * Infection: especially common in children ** Mycoplasma pneumoniae: moderate to severe involvement of two or more mucosal sites and sparse, or even absent...") Β |
m (ββ) Β |
||
(4 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
β | == |
+ | ==Etiology== |
+ | |||
β | * |
+ | *Infection: especially common in children |
β | ** |
+ | **[[Mycoplasma pneumoniae]]: moderate to severe involvement of two or more mucosal sites and sparse, or even absent, skin involvement |
β | ** |
+ | **[[Neisseria gonorrhoeae]][[CiteRef::tan2012pr]] |
β | * |
+ | *Drugs |
β | ** |
+ | **[[Allopurinol]] |
β | ** |
+ | **Aromatic [[antiepileptic drugs]] and [[lamotrigine]] |
β | ** |
+ | **Antibacterial sulfonamides (including [[sulfamethoxazole]] and [[sulfasalazine]]) |
β | ** |
+ | **[[Nevirapine]] |
β | ** |
+ | **[[Oxicam]] nonsteroidal anti-inflammatory drugs (NSAIDs) |
β | ** |
+ | **Less strongly, other antibiotics |
β | *** [[Doxycycline]] |
||
β | *** |
+ | ***[[Doxycycline]] |
β | *** |
+ | ***[[Amoxicillin]]/[[ampicillin]] |
β | *** |
+ | ***[[Ciprofloxacin]] |
β | *** |
+ | ***[[Levofloxacin]] |
+ | ***[[Rifampin]] |
||
+ | |||
+ | == Management == |
||
+ | |||
+ | * Risk stratify with [[SCORTEN score]] |
||
+ | * Consider referral to burn centre or ICU if [[BSA]] 30% or greater, or if SCORTEN score is 2 or greater |
||
+ | *Stop offending drug, if applicable |
||
+ | *Supportive care, including wound care and IV fluids (2 ml per kg times BSA over first 24 hours) |
||
+ | **Room temperature 30ΒΊ to 32ΒΊC |
||
+ | **May need NG tube |
||
+ | **Pain control, as pain may be severe |
||
+ | *Ophthalmologic exam and management |
||
+ | **Saline rinses |
||
+ | **Artificial tears even if no involvement |
||
+ | **Corticosteroids with or without antibiotics for any involvement |
||
+ | *No clear benefit to steroids or IVIG |
||
+ | *Cyclosporine 3 to 5 mg per kg in one or two divided doses may slow progression |
Latest revision as of 09:39, 10 April 2024
Etiology
- Infection: especially common in children
- Mycoplasma pneumoniae: moderate to severe involvement of two or more mucosal sites and sparse, or even absent, skin involvement
- Neisseria gonorrhoeae1
- Drugs
- Allopurinol
- Aromatic antiepileptic drugs and lamotrigine
- Antibacterial sulfonamides (including sulfamethoxazole and sulfasalazine)
- Nevirapine
- Oxicam nonsteroidal anti-inflammatory drugs (NSAIDs)
- Less strongly, other antibiotics
Management
- Risk stratify with SCORTEN score
- Consider referral to burn centre or ICU if BSA 30% or greater, or if SCORTEN score is 2 or greater
- Stop offending drug, if applicable
- Supportive care, including wound care and IV fluids (2 ml per kg times BSA over first 24 hours)
- Room temperature 30ΒΊ to 32ΒΊC
- May need NG tube
- Pain control, as pain may be severe
- Ophthalmologic exam and management
- Saline rinses
- Artificial tears even if no involvement
- Corticosteroids with or without antibiotics for any involvement
- No clear benefit to steroids or IVIG
- Cyclosporine 3 to 5 mg per kg in one or two divided doses may slow progression
References
- ^ SK Tan, YK Tay. Profile and Pattern of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in a General Hospital in Singapore: Treatment Outcomes. Acta Dermato Venereologica. 2012;92(1):62-66. doi:10.2340/00015555-1169.